APA Citatie

Hook, L. M., Awasthi, S., Dubin, J., Flechtner, J., Long, D., & Friedman, H. M. (2018). A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection. Vaccine.

Chicago Style citaat

Hook, Lauren M., Sita Awasthi, Jonathan Dubin, Jessica Flechtner, Deborah Long, en Harvey M. Friedman. "A Trivalent GC2/gD2/gE2 Vaccine for Herpes Simplex Virus Generates Antibody Responses That Block Immune Evasion Domains On GC2 Better Than Natural Infection." Vaccine 2018.

MLA citatie

Hook, Lauren M., et al. "A Trivalent GC2/gD2/gE2 Vaccine for Herpes Simplex Virus Generates Antibody Responses That Block Immune Evasion Domains On GC2 Better Than Natural Infection." Vaccine 2018.